Epilepsy trials in Mexico

In Mexico 9 Also abroad 452

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Where
Culiacán, Guadalajara, Mexico City
Age
4 years to 55 years
People
252 worldwide
Run by
SK Life Science, Inc.
See details and how to joinNCT05219617
Phase 3Taking people
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Where
Mexico City, Sinaloa
Age
12 years and over
People
160 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05667142 · EU 2022-502286-16-00
Phase 3Taking people
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Where
Benito Juárez, Mexico City, Monterrey, Sinaloa
Age
18 years and over
People
360 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05716100 · EU 2022-502281-25-00
Phase 3Enrolling by invitation
An Open-label Study of XEN1101 in Epilepsy
Where
Mexico City, Nuevo León, Sinaloa
Age
12 years and over
People
880 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05718817 · EU 2022-502282-24-00
No phaseTaking people
Artificial Intelligence for Brain MRI Analysis in Epilepsy
Where
Mexico City
People
2,000 worldwide
Run by
Istituto Giannina Gaslini
See details and how to joinNCT07881185
Phase 3Enrolling by invitation
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
Where
Mexico City
Age
2 years to 66 years
People
324 worldwide
Run by
Longboard Pharmaceuticals
See details and how to joinNCT06908226 · EU 2024-514974-39-00
Phase 3Taking people
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
Where
Aguascalientes, Culiacán, Guadalajara
Age
1 month and over
People
70 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT04715646
Phase 2Enrolling by invitation
Long-term Safety and Tolerability of BHV-7000
Where
Mexico City, Monterrey, Obispado, Sinaloa, Tlalnepantla, Veracruz
Age
18 years to 75 years
People
660 worldwide
Run by
Biohaven Therapeutics Ltd.
See details and how to joinNCT06443463 · EU 2023-508813-18-00
No phaseEnrolling by invitation
Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)
Where
Monterrey
Age
2 years to 65 years
People
25
Run by
Healing Hope International
See details and how to joinNCT07264166